BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34484860)

  • 1. EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop.
    Lin J; Zeng C; Zhang J; Song Z; Qi N; Liu X; Zhang Z; Li A; Chen F
    Mol Ther Nucleic Acids; 2021 Sep; 25():328-341. PubMed ID: 34484860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of EFNA4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating PYGO2.
    Yuan W; Zhao H; Zhou A; Wang S
    Cancer Biol Ther; 2022 Dec; 23(1):1-12. PubMed ID: 36404439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation.
    Ye P; Chen Z; Lou H; Mai Y; Zhu X; Fu X
    J Clin Exp Hepatol; 2023; 13(5):767-773. PubMed ID: 37693261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma.
    Huang S; Dong C; Zhang J; Fu S; Lv Y; Wu J
    Front Mol Biosci; 2022; 9():943384. PubMed ID: 36052169
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis.
    Zhao X; Chen Y; Sun X; He Z; Wu T; Wu C; Chen J; Wang J; Diao K; Liu XS
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
    Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
    Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression.
    Trinidad EM; Ballesteros M; Zuloaga J; Zapata A; Alonso-Colmenar LM
    Blood; 2009 Dec; 114(24):5081-90. PubMed ID: 19828693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells
    Wang J; Cao C; Zeng Q; Dong Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):679-684. PubMed ID: 31270046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.
    Lin X; Xiaoqin H; Jiayu C; Li F; Yue L; Ximing X
    Hepatol Res; 2019 Aug; 49(8):902-918. PubMed ID: 30945380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
    Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
    Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.
    Li T; Zhong J; Dong X; Xiu P; Wang F; Wei H; Wang X; Xu Z; Liu F; Sun X; Li J
    Oncol Rep; 2016 Jun; 35(6):3614-22. PubMed ID: 27109804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/β-catenin signaling pathway.
    Guo F; Wang H; Jiang M; Yang Q; Xiang Q; Zhou H; Hu X; Hao K; Yang J; Cao H; Shen Z
    Am J Cancer Res; 2020; 10(10):3285-3301. PubMed ID: 33163270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermidine/spermine N1-acetyltransferase regulates cell growth and metastasis via AKT/β-catenin signaling pathways in hepatocellular and colorectal carcinoma cells.
    Wang C; Ruan P; Zhao Y; Li X; Wang J; Wu X; Liu T; Wang S; Hou J; Li W; Li Q; Li J; Dai F; Fang D; Wang C; Xie S
    Oncotarget; 2017 Jan; 8(1):1092-1109. PubMed ID: 27901475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling.
    Zhou ZJ; Luo CB; Xin HY; Hu ZQ; Zhu GQ; Li J; Zhou SL
    NPJ Genom Med; 2020; 5():15. PubMed ID: 32257385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
    You Y; Zheng Q; Dong Y; Wang Y; Zhang L; Xue T; Xie X; Hu C; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    PLoS One; 2015; 10(8):e0134243. PubMed ID: 26280346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
    J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.